← Open Payments lookup

CHRISTY JAGGERS: Open Payments

NPI 1295017317 · AMORY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$676 in 35 payments from 10 companies in 2025. Trend: 2023 $960 · 2024 $622 · 2025 $676

Food & beverage: $676
CompanyPaymentsAmount
Fresenius USA Marketing, Inc.15$272
Calliditas Therapeutics US Inc.4$100
Otsuka America Pharmaceutical, Inc.4$84
Travere Therapeutics, Inc.3$48
Bayer Healthcare Pharmaceuticals Inc.2$47
Novartis Pharmaceuticals Corporation2$44
Novo Nordisk Inc2$30
Amgen Inc.1$20
Ardelyx, Inc.1$17
Boehringer Ingelheim Pharmaceuticals, Inc.1$14

Products named: VELPHORO, TARPEYO, JYNARQUE, Kerendia, Fabhalta, Ozempic, KRYSTEXXA, IBSRELA.

Industry payments across MS — which companies pay providers there.